# Disease, Disability, and Injury Prevention and Control
Special Emphasis Panels (SEP): Reducing Racial and Ethnic Disparities in Childhood Immunization, RFA IP 05-087; Influenza Vaccination of Healthcare Workers in Hospitals, RFA IP 05-089; Expanding Utilization of Pro-Active Pharmacist Pneumococcal Vaccination Programs, RFA IP 05-092; and CDC Disparities in Elderly Pneumococcal Vaccination, RFA IP 05-093.
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the following meeting:
*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Reducing Racial and Ethnic Disparities in Childhood Immunization, RFA IP 05-087; Influenza Vaccination of Healthcare Workers in Hospitals, RFA IP 05-089; Expanding Utilization of Pro-Active Pharmacist Pneumococcal Vaccination Programs, RFA IP 05-092; and CDC Disparities in Elderly Pneumococcal Vaccination, RFA IP 05-093.
*Times and Dates:* 8 a.m.-5 p.m., August 9, 2005 (Closed).
*Place:* Renaissance Concourse Hotel, One Hartsfield Centre Parkway, Atlanta, GA 30354, Telephone Number (404) 209-9999.
*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to: Reducing Racial and Ethnic Disparities in Childhood Immunization, RFA IP 05-087; Influenza Vaccination of Healthcare Workers in Hospitals, RFA IP 05-089; Expanding Utilization of Pro-Active Pharmacist Pneumococcal Vaccination Programs, RFA IP 05-092; and CDC Disparities in Elderly Pneumococcal Vaccination, RFA IP 05-093.
*Contact Person for More Information:* H. Mac Stiles, PhD, D.D.S, M.P.H., Scientific Review Administrator, 24 Executive Park, NE., Mailstop E74, Atlanta, GA 30333, Telephone (404) 498-2530.
The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: July 19, 2005.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.